These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 32663408)

  • 21. The emergence of the C-H functionalization strategy in medicinal chemistry and drug discovery.
    Jana R; Begam HM; Dinda E
    Chem Commun (Camb); 2021 Oct; 57(83):10842-10866. PubMed ID: 34596175
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Finding the sweet spot: the role of nature and nurture in medicinal chemistry.
    Hann MM; Keserü GM
    Nat Rev Drug Discov; 2012 Apr; 11(5):355-65. PubMed ID: 22543468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The Drug Discovery Portal: a resource to enhance drug discovery from academia.
    Clark RL; Johnston BF; Mackay SP; Breslin CJ; Robertson MN; Harvey AL
    Drug Discov Today; 2010 Aug; 15(15-16):679-83. PubMed ID: 20547242
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Physicochemical descriptors of aromatic character and their use in drug discovery.
    Ritchie TJ; Macdonald SJ
    J Med Chem; 2014 Sep; 57(17):7206-15. PubMed ID: 24856517
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ligand efficiency metrics in drug discovery: the pros and cons from a practical perspective.
    Cavalluzzi MM; Mangiatordi GF; Nicolotti O; Lentini G
    Expert Opin Drug Discov; 2017 Nov; 12(11):1087-1104. PubMed ID: 28814111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. On the origins of three-dimensionality in drug-like molecules.
    Meyers J; Carter M; Mok NY; Brown N
    Future Med Chem; 2016 Sep; 8(14):1753-67. PubMed ID: 27572621
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The impact of physicochemical and molecular properties in drug design: navigation in the "drug-like" chemical space.
    Vallianatou T; Giaginis C; Tsantili-Kakoulidou A
    Adv Exp Med Biol; 2015; 822():187-94. PubMed ID: 25416989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modeling of activity landscapes for drug discovery.
    Bajorath J
    Expert Opin Drug Discov; 2012 Jun; 7(6):463-73. PubMed ID: 22475223
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Global medicinal chemistry and GPCR conference: interview with Stevan Djuric.
    Djuric S
    Future Med Chem; 2018 Apr; 10(8):837-838. PubMed ID: 29580099
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NMR quantification of H-bond donating ability for bioactive functional groups and isosteres.
    Jennings JJ; Milic M; Targos K; Franz AK
    Eur J Med Chem; 2020 Dec; 207():112693. PubMed ID: 32862126
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Designing a new Diels-Alderase: a combinatorial, semirational approach including dynamic optimization.
    Linder M; Johansson AJ; Olsson TS; Liebeschuetz J; Brinck T
    J Chem Inf Model; 2011 Aug; 51(8):1906-17. PubMed ID: 21780795
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Stabilization of protein-protein interactions in drug discovery.
    Andrei SA; Sijbesma E; Hann M; Davis J; O'Mahony G; Perry MWD; Karawajczyk A; Eickhoff J; Brunsveld L; Doveston RG; Milroy LG; Ottmann C
    Expert Opin Drug Discov; 2017 Sep; 12(9):925-940. PubMed ID: 28695752
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Present drug-likeness filters in medicinal chemistry during the hit and lead optimization process: how far can they be simplified?
    Mignani S; Rodrigues J; Tomas H; Jalal R; Singh PP; Majoral JP; Vishwakarma RA
    Drug Discov Today; 2018 Mar; 23(3):605-615. PubMed ID: 29330127
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Significant Role of Chemistry in Drug Development: A Systematic Journey from Traditional to Modern Approaches with Anti-HIV/AIDS Drugs as Examples.
    Yadav M; Srivastava R; Naaz F; Verma R; Singh RK
    Curr Pharm Des; 2022; 28(3):232-247. PubMed ID: 34727852
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Druggable pockets and binding site centric chemical space: a paradigm shift in drug discovery.
    Pérot S; Sperandio O; Miteva MA; Camproux AC; Villoutreix BO
    Drug Discov Today; 2010 Aug; 15(15-16):656-67. PubMed ID: 20685398
    [TBL] [Abstract][Full Text] [Related]  

  • 36. From fragment screening to potent binders: strategies for fragment-to-lead evolution.
    Eitner K; Koch U
    Mini Rev Med Chem; 2009 Jul; 9(8):956-61. PubMed ID: 19601891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. On the Promise of Photopharmacology Using Photoswitches: A Medicinal Chemist's Perspective.
    Fuchter MJ
    J Med Chem; 2020 Oct; 63(20):11436-11447. PubMed ID: 32511922
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fragment-based ligand discovery.
    Fischer M; Hubbard RE
    Mol Interv; 2009 Feb; 9(1):22-30. PubMed ID: 19299661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A minimalist fragment approach for the design of natural-product-like synthetic scaffolds.
    Genis D; Kirpichenok M; Kombarov R
    Drug Discov Today; 2012 Nov; 17(21-22):1170-4. PubMed ID: 22659098
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.
    Blum LC; Reymond JL
    J Am Chem Soc; 2009 Jul; 131(25):8732-3. PubMed ID: 19505099
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.